Anthera Raises $47M

Xconomy San Francisco — 

Hayward, CA-based Anthera Pharmaceuticals (NASDAQ: ANTH) said today it raised $47 million through a stock offering, after deducting expenses. The company sold about 6.7 million shares of stock at $7.50 apiece, and granted its underwriters a 30-day option to buy another 1 million shares. Citi, Leerink Swann, and Canaccord Genuity managed the offering.